Finance

Lists
DPHARMA:KLSE
Duopharma Biotech Bhd
1,13 MYR
+0,89%
(+0,0100) 1D
9 қаз., 17:00:00 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
1,13 MYR
High
1,14 MYR
Low
1,13 MYR
Mkt. cap
1,09 млрд
Avg. vol.
394,22 м.
Volume
76,30 мың
Dividend
4,03%
Quarterly dividend
0,01 MYR
Ex-dividend date
2026 ж. 03 қыр.
P/E ratio
10,64
52-wk high
1,57 MYR
52-wk low
1,12 MYR
EPS
0,11 MYR
Shares outstanding
961,94 млн
No. of employees
2 мың
Open
1,13 MYR
High
1,14 MYR
Low
1,13 MYR
Mkt. cap
1,09 млрд
Avg. vol.
394,22 м.
Volume
76,30 мың
Dividend
4,03%
Quarterly dividend
0,01 MYR
Ex-dividend date
2026 ж. 03 қыр.
P/E ratio
10,64
52-wk high
1,57 MYR
52-wk low
1,12 MYR
EPS
0,11 MYR
Shares outstanding
961,94 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Duopharma Biotech Bhd
CEO-
Employees2 мың
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
222,49 млн
224,69 млн
247,88 млн
234,36 млн
Cost of goods sold
131,74 млн
128,63 млн
150,58 млн
134,89 млн
Cost of revenue
131,74 млн
128,63 млн
150,58 млн
134,89 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,11 млн
64,37 млн
52,42 млн
55,74 млн
Operating expense
56,18 млн
66,90 млн
52,88 млн
55,60 млн
Total operating expenses
187,93 млн
195,53 млн
203,46 млн
190,50 млн
Operating income
34,56 млн
29,15 млн
44,42 млн
43,86 млн
Other non operating income
-
-590,00 м.
-
-
EBT including unusual items
29,68 млн
24,91 млн
40,41 млн
39,30 млн
EBT excluding unusual items
29,68 млн
24,90 млн
40,41 млн
39,30 млн
Income tax expense
7,11 млн
5,86 млн
9,69 млн
9,43 млн
Effective tax rate
23,96%
23,52%
23,99%
24,00%
Other operating expenses
76,00 мың
2,00 млн
468,00 м.
-130,00 м.
Net income
22,57 млн
19,05 млн
30,71 млн
29,87 млн
Net profit margin
10,14%
8,48%
12,39%
12,75%
Earnings per share
-
-
-
-
Interest and investment income
1,53 млн
1,52 млн
1,58 млн
1,34 млн
Interest expense
-6,40 млн
-5,19 млн
-5,60 млн
-5,89 млн
Net interest expenses
-4,88 млн
-3,67 млн
-4,02 млн
-4,56 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
45,74 млн
32,61 млн
55,43 млн
54,75 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары